Ha habido 50 transacciones internas recientes registradas para HOOKIPA Pharma Inc. (HOOK), incluyendo 44 compras y 2 ventas. El total de compras internas fue valorado en $4.56M y el total de ventas internas en $29.48K.
Internos destacados con actividad reciente incluyen Cassidy Sean A, Coelho Mary Theresa, Peters Malte. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — HOOK
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-07-22 |
Cassidy Sean A |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-07-22 |
Cassidy Sean A |
Director |
Concesión de RSU |
9,800 |
$6.44 |
$63.11K |
9,800 |
| 2024-07-22 |
Coelho Mary Theresa |
EVP and CFO |
Concesión de RSU |
69,875 |
- |
- |
69,875 |
| 2024-07-22 |
Peters Malte |
Chief Executive Officer |
Concesión de RSU |
108,695 |
- |
- |
108,695 |
| 2024-06-17 |
O'neill Julie |
Director |
Concesión de RSU |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Coelho Mary Theresa |
Director |
Concesión de RSU |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Van De Winkel Jan |
Director |
Concesión de RSU |
98,000 |
$0.71 |
$69.58K |
98,000 |
| 2024-06-17 |
Kaufman David Ross |
Director |
Concesión de RSU |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Peters Malte |
Director |
Concesión de RSU |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-06-17 |
Reilly Timothy P. |
Director |
Concesión de RSU |
49,000 |
$0.71 |
$34.79K |
49,000 |
| 2024-04-15 |
Aldag Jorn |
Chief Executive Officer |
Concesión de RSU |
971,400 |
$0.76 |
$738.26K |
971,400 |
| 2024-04-15 |
Kandera Reinhard |
Chief Financial Officer |
Concesión de RSU |
406,200 |
$0.76 |
$308.71K |
406,200 |
| 2024-04-15 |
Orlinger Klaus |
Chief Scientific Officer |
Concesión de RSU |
367,300 |
$0.76 |
$279.15K |
367,300 |
| 2024-04-15 |
Necina Roman |
Chief Operations Officer |
Concesión de RSU |
367,300 |
$0.76 |
$279.15K |
367,300 |
| 2024-04-15 |
Winderlich Mark |
Chief Development Officer |
Concesión de RSU |
50,000 |
$0.76 |
$38K |
50,000 |
| 2024-04-01 |
Winderlich Mark |
Officer |
Desconocido |
- |
- |
- |
- |
| 2023-12-20 |
Gilead Sciences, Inc. |
10 Percent Owner |
Disposición |
- |
- |
- |
18,759,465 |
| 2023-08-21 |
Kandera Reinhard |
Chief Financial Officer |
Compra Informativa |
7,000 |
$0.73 |
$5.08K |
43,092 |
| 2023-08-16 |
Kandera Reinhard |
Chief Financial Officer |
Compra Informativa |
8,000 |
$0.71 |
$5.71K |
36,092 |
| 2023-07-11 |
Aldag Jorn |
Chief Executive Officer |
Compra Informativa |
5,000 |
$0.83 |
$4.14K |
71,952 |
| 2023-07-07 |
Aldag Jorn |
Chief Executive Officer |
Compra Informativa |
5,000 |
$0.81 |
$4.05K |
66,952 |
| 2023-07-05 |
Aldag Jorn |
Chief Executive Officer |
Compra Informativa |
5,000 |
$0.89 |
$4.45K |
61,952 |
| 2023-07-03 |
Aldag Jorn |
Chief Executive Officer |
Compra Informativa |
5,000 |
$0.89 |
$4.46K |
56,952 |
| 2023-06-30 |
Kandera Reinhard |
Chief Financial Officer |
Compra Informativa |
12,000 |
$0.88 |
$10.56K |
28,092 |
| 2023-06-09 |
O'neill Julie |
Director |
Concesión de RSU |
26,000 |
$1.01 |
$26.26K |
26,000 |
| 2023-06-09 |
Coelho Mary Theresa |
Director |
Concesión de RSU |
52,000 |
$1.01 |
$52.52K |
52,000 |
| 2023-06-09 |
Van De Winkel Jan |
Director |
Concesión de RSU |
52,000 |
$1.01 |
$52.52K |
52,000 |
| 2023-06-09 |
Kaufman David Ross |
Director |
Concesión de RSU |
26,000 |
$1.01 |
$26.26K |
26,000 |
| 2023-06-09 |
Peters Malte |
Director |
Concesión de RSU |
52,000 |
$1.01 |
$52.52K |
52,000 |
| 2023-06-09 |
Reilly Timothy P. |
Director |
Concesión de RSU |
26,000 |
$1.01 |
$26.26K |
26,000 |
| 2023-04-14 |
Aldag Jorn |
Chief Executive Officer |
Concesión de RSU |
513,600 |
$1.00 |
$513.6K |
513,600 |
| 2023-04-14 |
Kandera Reinhard |
Chief Financial Officer |
Concesión de RSU |
214,800 |
$1.00 |
$214.8K |
214,800 |
| 2023-04-14 |
Orlinger Klaus |
Chief Scientific Officer |
Concesión de RSU |
194,200 |
$1.00 |
$194.2K |
194,200 |
| 2023-04-14 |
Necina Roman |
Chief Development Officer |
Concesión de RSU |
112,100 |
$1.00 |
$112.1K |
112,100 |
| 2023-04-14 |
Baker Christine D. |
Chief Operating Officer |
Concesión de RSU |
275,800 |
$1.00 |
$275.8K |
275,800 |
| 2023-04-14 |
Schlienger Katia |
Chief Medical Officer |
Concesión de RSU |
184,000 |
$1.00 |
$184K |
184,000 |
| 2023-04-03 |
Coelho Mary Theresa |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-03-09 |
Schlienger Katia |
Chief Medical Officer |
Disposición |
17,760 |
$1.66 |
$29.48K |
- |
| 2023-01-01 |
Peters Malte |
Director |
Desconocido |
- |
- |
- |
- |
| 2022-06-30 |
O'neill Julie |
Director |
Concesión de RSU |
20,000 |
- |
- |
20,000 |
| 2022-06-30 |
Aldag Jorn |
Chief Executive Officer |
Concesión de RSU |
275,250 |
$1.66 |
$456.92K |
275,250 |
| 2022-06-30 |
Van De Winkel Jan |
Director |
Concesión de RSU |
40,000 |
$1.63 |
$65.2K |
40,000 |
| 2022-06-30 |
Matushansky Igor |
Chief Medical Officer |
Concesión de RSU |
92,950 |
- |
- |
92,950 |
| 2022-06-30 |
Kandera Reinhard |
Chief Financial Officer |
Concesión de RSU |
92,950 |
$1.66 |
$154.3K |
92,950 |
| 2022-06-30 |
Orlinger Klaus |
Chief Scientific Officer |
Concesión de RSU |
48,350 |
$1.66 |
$80.26K |
48,350 |
| 2022-06-30 |
Kelly Michael Aaron |
Director |
Concesión de RSU |
20,000 |
- |
- |
20,000 |
| 2022-06-30 |
Kaufman David Ross |
Director |
Concesión de RSU |
20,000 |
- |
- |
20,000 |
| 2022-06-30 |
Necina Roman |
Chief Technology Officer |
Concesión de RSU |
48,350 |
$1.66 |
$80.26K |
48,350 |
| 2022-06-30 |
Baker Christine D. |
Chief Operating Officer |
Concesión de RSU |
100,000 |
- |
- |
100,000 |
| 2022-06-30 |
Reilly Timothy P. |
Director |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
